GUARNERI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 4.802
AS - Asia 2.524
EU - Europa 1.515
SA - Sud America 346
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 1
Totale 9.294
Nazione #
US - Stati Uniti d'America 4.680
SG - Singapore 879
CN - Cina 709
DE - Germania 410
VN - Vietnam 290
BR - Brasile 273
UA - Ucraina 255
TR - Turchia 239
IT - Italia 192
HK - Hong Kong 189
FI - Finlandia 155
GB - Regno Unito 145
SE - Svezia 94
FR - Francia 91
RU - Federazione Russa 58
CA - Canada 55
JP - Giappone 53
MX - Messico 45
AR - Argentina 37
IN - India 32
BD - Bangladesh 28
PL - Polonia 28
ZA - Sudafrica 26
NL - Olanda 19
PK - Pakistan 16
LT - Lituania 14
ES - Italia 13
CZ - Repubblica Ceca 11
IQ - Iraq 11
BE - Belgio 10
CI - Costa d'Avorio 10
MA - Marocco 10
CO - Colombia 9
ID - Indonesia 9
JO - Giordania 8
KR - Corea 8
CL - Cile 7
EC - Ecuador 6
EG - Egitto 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
PH - Filippine 5
SA - Arabia Saudita 5
TW - Taiwan 5
UZ - Uzbekistan 5
IR - Iran 4
LB - Libano 4
TN - Tunisia 4
AT - Austria 3
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
MY - Malesia 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
BB - Barbados 2
BH - Bahrain 2
CR - Costa Rica 2
DM - Dominica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
NO - Norvegia 2
PE - Perù 2
SV - El Salvador 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DZ - Algeria 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 9.261
Città #
Singapore 599
Ashburn 437
Woodbridge 374
Fairfield 356
San Jose 342
Jacksonville 275
Ann Arbor 273
Beijing 249
Chandler 245
Santa Clara 233
Houston 230
Hong Kong 186
Munich 176
Seattle 170
Wilmington 132
New York 129
Cambridge 127
Ho Chi Minh City 104
Izmir 98
Council Bluffs 94
Nanjing 94
Addison 87
Los Angeles 84
Hanoi 66
Helsinki 66
Dallas 52
Princeton 52
Tokyo 51
Lauterbourg 49
Bremen 37
Shanghai 36
Turku 36
San Diego 34
Milan 32
Mexico City 30
Shenyang 29
São Paulo 25
Frankfurt am Main 23
Jiaxing 23
Nanchang 23
London 21
Toronto 19
Changsha 18
Chicago 18
San Mateo 17
Tianjin 17
Warsaw 17
Boardman 16
Buffalo 16
Brooklyn 15
Orem 15
Da Nang 14
Haiphong 14
The Dalles 14
Falkenstein 13
Hefei 13
Johannesburg 13
Poplar 13
Montreal 12
Amsterdam 11
Denver 11
Stockholm 11
Atlanta 10
Bologna 10
Hebei 10
Jinan 10
Wroclaw 10
Abidjan 9
Boston 9
Brussels 9
Dearborn 9
Hải Dương 9
Mumbai 9
Belo Horizonte 8
Moscow 8
Phoenix 8
Torre Del Greco 8
Falls Church 7
Newport 7
Norwalk 7
Porto Alegre 7
Amman 6
Chengdu 6
Chennai 6
Curitiba 6
Leawood 6
Olomouc 6
Ottawa 6
Philadelphia 6
Baghdad 5
Can Tho 5
Nairobi 5
Nha Trang 5
Orange 5
Rio de Janeiro 5
San Francisco 5
Taizhou 5
Washington 5
Zhengzhou 5
Ankara 4
Totale 6.352
Nome #
Imidazo[4,5-c]pyrazoles Synthesis of 4-,5- and 6-Substituted Derivatives 343
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 284
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 274
A synthetic entry to isoxazolo[5,4‐d]pyrimidine‐4(5H)thione and isothiazolo[4,3‐d]isoxazole 261
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 258
A NEW FUSED HETEROCYCLIC SYSTEM - 6H-PYRAZOLO[3,4-C][1,2,5]THIADIAZINE 2,2-DIOXIDE 249
4-[(N-BENZYLOXYCARBONYLVALYL)OXYIMINO]-3-METHYL-1-PHENYL-2-PYRAZOLIN-5-O NE 242
A new synthesis of pyrazolo[3,4-d]thiazoles 236
Carboxyl activation in peptide synthesis using 4-oximino-pyrazol-5-ones 225
A new general and efficient synthesis of imidazo[4,5-c]pyrazole derivatives 223
Reactivity of Pyrazolo[4,3-c] [1,2,5]oxadiazin- 3(5H)-ones toward C-nucleophiles: Synthesis of Pyrazolo[3,4-b] pyrazines 220
Reactivity of 3H-Pyrimido[5,4-c] [1,2,5]oxadiazin-3-one towards Carbanions: Synthesis of pteridine-2,4-diones 210
A New Procedure for the Synthesis of 4-H-Pyrazolo[1,5-c][1,3,5]thiadiazine-4-thiones 206
Cyclic guanidines: Synthesis of 4,6,7,8‐tetrahydro‐1H‐imidazo[1,2‐a]pyrazolo[3,4‐d]pyrimidin‐7‐ones and 1,4,6,7,8,9‐hexahydropyrazolo[3′,4′:4,5]pyrimido[2,1‐c] [1,2,4]triazin‐7‐ones 205
Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain 200
A new route to the synthesis of Somatostatin 200
Analoghi eterociclici dell’acido retinoico (eteroretinoidi) come potenziali agenti “anti-aging”. 192
A new Route to the Synthesis of Imidazo[4,5-c] pyrazoles 191
L’1,2-Dimetil-4-ossimino-3,5-pirazolidindione come attivatore nella sintesi peptidica 184
3-Methylimidazo[4,5-c]pyrazoles having therapeutic activity 178
Derivati del 6-trifluorometil-pirazolo[3,4-d]pirimidin-4(5H)tioni quali fitofarmaci ad azione fungicida, procedimento per la loro preparazione e composizioni anticrittogamiche che li contengono 178
Synthesis and Prostaglandin-like Activity of 2-(trans-3-Hydroxy-1-octenyl)-3-indolheptanoic Acid 175
An efficient procedure for the synthesis of pyrazolo[3,4-d] [1,3]thiazin-4-ones 173
Human leukocyte elastase inhibitor design: CoMFA analysis contributions to pyrazolo-oxadiazinones design 171
Sintesi di derivati pirazolici e pirazolo[4,3-d]pirimidonici. Nota I 171
Pyrazole-Related Nucleosides. Synthesis and Antiviral/Antitumor Activity of Some Substituted Pyrazole and Pyrazolo[4,3-d]-1,2,3-triazin-4-one Nucleosides 170
New synthesis of growth-hormone releasing hormone by the pyrazoline active ester procedure 169
Synthesis of 1-phenyl-substituted 3-methyl-1H-pyrazolo[3,4-b]pyrazine-5,6-dicarboxylic acid diethyl esters. 168
Synthesis and In-vitro Antifungal Activity of 6-Trifluoromethylpyrazolo[3,4-d]pyrimidines 160
Synthesis of 4‐thiocarbamoyl‐5‐aminopyrazoles 159
Fungitoxicity of 6H-Pyrazolo[3,4-c] [1,2,5]thiadiazine 2,2-Dioxides 157
Pyrazolo[3,4-d] [1,2,3]triazole-1-carboxamides and 5-alkylamino pyrazolo[3,4-d]oxazoles: synthesis and evaluation of the in vitro antifungal activity 156
Synthesis of N-alkyl-N’-(4-diazo-5-pyrazolyl)ureas and their conversion into pyrazolo[3,4-d] [1,2,3]triazole and pyrazolo[3,4-d]oxazole derivatives 156
A New Efficient Route to Imidazo[4,5-c]pyrazole-5-ones 155
Building a hypotesis for human leukocyte elastase inhibition by bifunctional condensed heterocycles 154
Cocktail Mdelling Study on potential Mechanism Based Inhibitors of Human Leukocyte Helastase 153
Synthesis of 14-hydroxy-8-azaprostanoic acids methyl ester 153
Synthesis of 6,7-Disubstituted Pteridine –2,4-Diones 148
Synthesis and Cytostatic Activity of Geiparvarin Analogues 147
Progettazione, sintesi ad attività biologica di analoghi eterociclici dell’acido retinoico (eteroretinoidi) come potenziali anti-aging. 145
Synthesis and antifungal activity of 4-thiazol-2-yl-5-aminopyrazoles and 4-aminopyrazolo[3,4-c]isothiazoles 145
Synthesis of 3-Methyl-6-phenylamino-substituted-1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones 144
Synthesis and evaluation of the antifungal activity of a new class of N-acylureas 142
Reactions of oxadiazinones with beta-enaminones Regioselective synthesis of pyrazolo-pyrazines and pteridines 131
Use of [3 + 2] Cycloaddition in Elaboration of the ɷ Chain of Prostaglandins 129
Fungitoxicity of 5-aminoisoxazole-4-thiocyanates Derivatives 128
Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II 125
Synthesis and antifungal activity of pyrazolo[3,4-d]pyrimidin –4(5H)-thiones 117
Synthesis and In-vitro Antifungal Activity of 6-Trifluoromethylpyrazolo[3,4-d]pyrimidin-4(5H)-thiones 116
Hypoglycemic compounds. Sulfanylurea derivatives containing amino acids and dipeptides. I 101
Modificazioni molecolari di vitamine antiossidanti come mezzo per ottenere anti-aging 80
Synthesis of compounds of antisecretory activity. 73
null 64
Totale 9.294
Categoria #
all - tutte 40.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022572 0 41 17 33 82 27 6 16 37 38 57 218
2022/2023551 59 52 15 58 97 79 18 50 70 3 36 14
2023/2024308 26 32 7 2 7 77 46 22 2 9 8 70
2024/20251.264 25 33 96 59 134 125 84 67 138 134 176 193
2025/20263.252 391 122 251 447 527 247 388 135 263 337 110 34
2026/2027208 73 135 0 0 0 0 0 0 0 0 0 0
Totale 9.294